Search for: "Eli Lilly " Results 1541 - 1560 of 2,131
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jan 2012, 11:58 pm by Lawrence B. Ebert
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
2 Aug 2023, 7:00 am by Miquel Montañá (Clifford Chance)
To put in context the points discussed in the judgment, it will be useful to provide some background on the case: Eli Lilly owned a patent that protected the use of raloxifene in the preparation of a medicament useful for the prevention and treatment of osteoporosis. [read post]
5 Feb 2018, 4:16 am by Birgit Kramer
In C-493/12 – Eli Lilly and Company the CJEU had stressed that the “infringement test” was not to be applied for determining whether a product is “protected by a basic patent in force”. [read post]
2 Nov 2011, 4:53 am
  Meanwhile, the Respondent [Eli Lilly] brought parallel proceedings in the High Court for revocation of the Patent in the UK. [read post]
12 Nov 2020, 9:05 pm by Megan Russo
Eli Lilly expects to make up to one million doses of the treatment by the end of the year. [read post]
23 Apr 2024, 6:40 am by Dylan Gibbs
.🥀 Eli Lilly wanted a stiff reversal from the Federal Court of Appeal but that’s not how things played out. [read post]
13 Mar 2009, 2:00 am
(GenericsWeb) India’s Human Genome Bill (Spicy IP) Indian drugmakers push into US generics market (GenericsWeb) Uganda: Indian generic manufacturers concerned anti-counterfeit legislation may threaten market in Uganda and surrounding territories (Afro-IP) UK: Court of Appeal admonishes counsel for dilatory actions involved in parallel British and EPO proceedings: Eli Lilly & Co v Human Genome Sciences (Hal Wegner) (PatLit) US: President Obama to lift stem cell… [read post]
13 Mar 2017, 1:39 am by Simon Holzer
This is painful for the Eli Lilly group, as the patent was one of several elements to protect the successful Cialis® product. [read post]
6 Jan 2009, 9:14 am
Eli Lilly: - This addresses patent validity and enforceability issues where Lilly contends that the asserted claims of US 6,410,516 are invalid for including non-statutory subject matter, for being obtained through inequitable conduct, and are unenforceable due to prosecution laches. [read post]
7 Sep 2006, 2:01 pm
" On April 4, 2005, Eli Lilly and Company filed an ex parte request in the United States Patent and Trademark Office, or PTO, to reexamine the patentability of certain claims of the ‘516 Patent. [read post]
8 Mar 2018, 6:48 am
Following Actavis vs Eli Lilly, is the UK becoming more author-centric? [read post]
2 Jul 2017, 12:52 am
 (Eli Lilly v Novopharm (2010 FCA 197)This exercise requires:Reviewing the entire specification (claims and entire disclosure)Identifying the promises made in the entire specification Determining whether the patent fulfils those promises by demonstration or sound prediction.This exercise is a question of law viewed through the skilled person at the time of filing (with the assistance of expert evidence) and has been applied in several cases (BMS v Apotex (2005 FC 1348),… [read post]
14 Oct 2015, 10:21 am
 Larry Welch (Eli Lilly)Larry Welch from Eli Lilly concluded the presentation by outlining the position under US law which is simple - there is no requirement to remunerate inventors under US law. [read post]
21 Sep 2020, 12:00 am by Annsley Merelle Ward
At the time of writing the full judgement is not available, yet.Immediately after the nullity hearing, Eli Lilly filed for preliminary injunctions against generics. [read post]